Reported 5 months ago
Alphabet's investment fund, CapitalG, added two growth stocks to its $7 billion portfolio last quarter. The first is GitLab (NASDAQ: GTLB), a code repository management platform, which saw a substantial increase in Alphabet's stake. The second is Prime Medicine (NASDAQ: PRME), a biotech company focused on gene-editing therapies. While GitLab has shown strong revenue growth and potential for earnings growth, Prime Medicine is pre-revenue with a precarious financial situation. Despite the risks, both stocks have the backing of Alphabet and are worth considering for investment.
Source: YAHOO